RNGCX
Price
$64.05
Change
+$0.63 (+0.99%)
Updated
Jun 26 closing price
Net Assets
38.27B
RNPEX
Price
$67.73
Change
+$0.62 (+0.92%)
Updated
Jun 26 closing price
Net Assets
152.59B
Interact to see
Advertisement

RNGCX vs RNPEX

Header iconRNGCX vs RNPEX Comparison
Open Charts RNGCX vs RNPEXBanner chart's image
American Funds New Economy R3
Price$64.05
Change+$0.63 (+0.99%)
VolumeN/A
Net Assets38.27B
American Funds New Perspective R4
Price$67.73
Change+$0.62 (+0.92%)
VolumeN/A
Net Assets152.59B
RNGCX vs RNPEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RNGCX vs. RNPEX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNGCX is a Buy and RNPEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 153B vs. RNGCX (38.3B). RNPEX pays higher dividends than RNGCX: RNPEX (0.51) vs RNGCX (0.00). RNGCX was incepted earlier than RNPEX: RNGCX (23 years) vs RNPEX (23 years). RNGCX (1.06) is less costly to investors than RNPEX (0.76). RNGCX is a more actively managed with annual turnover of: 36.00 vs. RNPEX (24.00). RNGCX (250) and RNPEX (250) have matching initial minimum investment requirements. RNPEX annual gain was more profitable for investors over the last year : 10.84 vs. RNGCX (6.24). RNPEX return over 5 years is better than : 49.55 vs. RNGCX (40.28).
RNGCXRNPEXRNGCX / RNPEX
Total Expense Ratio1.060.76139%
Annual Report Gross Expense Ratio1.060.76139%
Fund Existence23 years23 years-
Gain YTD9.90011.19788%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets38.3B153B25%
Annual Yield % from dividends0.000.51-
Returns for 1 year6.2410.8458%
Returns for 3 years50.5640.13126%
Returns for 5 years40.2849.5581%
Returns for 10 years64.8282.4579%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBY0.600.03
+4.60%
NovaBay Pharmaceuticals
DEI15.090.49
+3.36%
Douglas Emmett
TRST33.080.80
+2.48%
TrustCo Bank Corp
DOX91.370.71
+0.78%
Amdocs Limited
CTNM4.01-0.58
-12.64%
Contineum Therapeutics